Trial Profile
Clinical Trials Insight: 700030010
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 21 Jan 2008
Price :
$35
*
At a glance
- Drugs GEM SP (Primary)
- Indications Multiple sclerosis
- Focus Adverse reactions; Therapeutic Use
- Sponsors GEMACBIO
- 21 Jan 2008 New trial record.